Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 366.50
Bid: 362.00
Ask: 365.00
Change: 2.50 (0.69%)
Spread: 3.00 (0.829%)
Open: 381.50
High: 381.50
Low: 364.00
Prev. Close: 364.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD)

29 Apr 2024 12:32

RNS Number : 4376M
Quanex Building Products Corp
29 April 2024
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Quanex Building Products Corporation ("Quanex")

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Quanex Building Products Corporation

(d) Is the discloser the offeror or the offeree?

OFFEROR

(e) Date position held:

The latest practicable date prior to the disclosure

29 April 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

units of common stock

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

 

NIL

 

NIL

 

NIL

 

(2) Cash-settled derivatives:

 

NIL

 

NIL

 

NIL

 

NIL

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

NIL

NIL

NIL

 

TOTAL:

NIL

NIL

NIL

NIL

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(a) The following directors of Quanex Building Products Corporation (including their close relatives and family trusts) have interests in the following securities in Quanex:

 

Quanex Director

Number of common stock units

Percentage of total Quanex share capital

George L. Wilson

233,1541

0.704%

Curtis M. Stevens

5,009

0.015%

Jason D. Lippert

20,450

0.062%

 

1 This figure includes 92,800 unvested restricted stock awards, of which 29,200 were granted on 7 December 2023, 34,100 were granted on 7 December 2022 and 29,500 were granted on 9 December 2021. Such stock is issued (with all rights attaching) to the holder on the date of grant on a conditional basis. Such unvested restricted stock awards are not transferrable prior to the vesting date, which in each case is the date which is 3 years from the date of grant (the "Restricted Period"). Pro rata early vesting occurs upon retirement, and full early vesting occurs on change in control, death, or disability. During the Restricted Period, the holder has voting rights but does not receive dividends. Dividends are accrued during the Restricted Period and are paid only when the shares vest.

 

(b) The following directors have interests in securities in Quanex pursuant to exercisable but unexercised options:

 

Quanex Director

Number of common stock units

Grant Date

Exercise period

Exercise price

George L. Wilson

17,100

30.11.2016

30.11.2026

$19.45

14,400

02.12.2015

02.12.2025

$19.31

6,300

03.12.2014

03.12.2024

$20.28

 

(c) The following directors have interests in securities in Quanex pursuant to unvested performance restricted stock unit awards:

 

Quanex Director

Number of common stock units

Grant date

Vesting Date

George L. Wilson

25,700

07.12.2023

07.12.2026

30,400

07.12.2022

07.12.2025

29,200

09.12.2021

09.12.2024

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

29 April 2024

Contact name:

Scott Zuehlke

Telephone number:

+1 713 877 5327

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEQKCBBDBKDFQB
Date   Source Headline
23rd Apr 20242:43 pmRNSForm 8.3 - Tyman plc
23rd Apr 20242:42 pmRNSForm 8.3 - Offer for Tyman plc
23rd Apr 20242:37 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20242:20 pmRNSForm 8.3 - QUANEX BUILDING PRODUCTS CORP
23rd Apr 20242:17 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20242:17 pmRNSForm 8.3 - TYMAN PLC
23rd Apr 20241:59 pmRNSForm 8.3 - Quanex Building Products Corporation
23rd Apr 20241:58 pmRNSForm 8.3 - Tyman plc
23rd Apr 20241:55 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tyman plc
23rd Apr 20241:22 pmRNSForm 8.3 - Tyman plc
23rd Apr 20241:14 pmEQSForm 8.3 - Apex Fundrock Limited : Re Tyman plc
23rd Apr 202412:48 pmGNWForm 8.3 - Tyman plc
23rd Apr 202412:22 pmRNSForm 8.3 - Tyman plc
23rd Apr 202412:10 pmGNWDimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
23rd Apr 202412:09 pmGNWMan Group PLC : Form 8.3 - Tyman plc
23rd Apr 202411:57 amRNSForm 8.3 - Tyman Plc
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.